AccessPak for HIV PEP Expanded with Kaletra and Olodaterol and tiotropium
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Olodaterol and tiotropium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: olodaterol / tiotropium
Brand name: Stiolto Respimat 28 ACT, Stiolto Respimat 60 ACT, Stiolto Respimat 10 ACT, Stiolto Respimat
Synonyms: Tiotropium and Olodaterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Olodaterol Hydrochloride
- AccessPak for HIV PEP Expanded with Kaletra-Olodaterol inhalation
- AccessPak for HIV PEP Expanded with Kaletra-Olopatadine nasal
- AccessPak for HIV PEP Expanded with Kaletra-Olopatadine Nasal Spray
- AccessPak for HIV PEP Expanded with Kaletra-Olsalazine
- AccessPak for HIV PEP Expanded with Kaletra-Olsalazine Sodium
- Olodaterol and tiotropium-AccessPak for HIV PEP Expanded with Viracept
- Olodaterol and tiotropium-Accolate
- Olodaterol and tiotropium-Accretropin
- Olodaterol and tiotropium-Accucaine
- Olodaterol and tiotropium-AccuHist Drops
- Olodaterol and tiotropium-AccuHist PDX Drops